World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
17540
World Ranking
4184
National Ranking
1908

Michelle A. Lifton publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michelle A. Lifton sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 83 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michelle A. Lifton D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michelle A. Lifton sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michelle A. Lifton is affiliated with the Beth Israel Deaconess Medical Center in the United States. Their research primarily focuses on medicine and immunology and microbiology, with significant contributions to infectious diseases, immunology, and molecular biology. The scientist's work also touches on oncology and epidemiology as subfields of study.

The main research topics covered by Lifton include SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, immune cell function and interaction, vaccines and immunoinformatics approaches, polyomavirus and related diseases, long-term effects of COVID-19, and immunotherapy and immune responses.

Michelle A. Lifton has published papers in several prominent scientific venues, with frequent publications in bioRxiv (Cold Spring Harbor Laboratory), Cell, Nature, the Journal of Virology, and The Journal of Infectious Diseases.

  • SARS-CoV-2 infection protects against rechallenge in rhesus macaques, 2020, Science
  • Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron, 2022, Nature
  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans, 2021, Nature
  • CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques, 2022, Science Immunology
  • Vaccine protection against the SARS-CoV-2 Omicron variant in macaques, 2022, Cell

Frequent co-authors in Lifton's research include Dan H. Barouch, Jinyan Liu, Katherine McMahan, Jingyou Yu, and Catherine Jacob-Dolan. These collaborations have contributed to the depth and breadth of work on vaccine responses and immune protection mechanisms related to SARS-CoV-2.

Best Publications

  • Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes

    Jörn E. Schmitz;Marcelo J. Kuroda;Sampa Santra;Vito G. Sasseville

  • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

    John W. Shiver;Tong-Ming Fu;Ling Chen;Danilo R. Casimiro

  • Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination

    Dan H. Barouch;Sampa Santra;Jörn E. Schmitz;Marcelo J. Kuroda

  • Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

    Norbert Pardi;Michael J. Hogan;Rebecca S. Pelc;Hiromi Muramatsu

  • SARS-CoV-2 infection protects against rechallenge in rhesus macaques.

    Abishek Chandrashekar;Jinyan Liu;Amanda J. Martinot;Amanda J. Martinot;Katherine McMahan

  • Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

    Dan H. Barouch;Jennifer Kunstman;Marcelo J. Kuroda;Jörn E. Schmitz

  • Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

    Diane M. Roberts;Anjali Nanda;Menzo J. E. Havenga;Peter Abbink

  • Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity

    Dan H. Barouch;Maria G. Pau;Jerome H. H. V. Custers;Wouter Koudstaal

  • Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein

    Shawn M. Sumida;Diana M. Truitt;Angelique A. C. Lemckert;Ronald Vogels

  • Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.

    Marcelo J. Kuroda;Jörn E. Schmitz;William A. Charini;Christine E. Nickerson

  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.

    Galit Alter;Galit Alter;Jingyou Yu;Jinyan Liu;Abishek Chandrashekar

  • Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

    Dan H. Barouch;Abie Craiu;Marcelo J. Kuroda;Jörn E. Schmitz

  • Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.

    Dan H. Barouch;Sampa Santra;Marcelo J. Kuroda;Jörn E. Schmitz

  • Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys

    Dan H. Barouch;Jennifer Kunstman;Jennifer Glowczwskie;Kevin J. Kunstman

  • Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors

    Shawn M. Sumida;Diana M. Truitt;Michael G. Kishko;Janelle C. Arthur

  • Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.

    Dan H. Barouch;Sampa Santra;Klara Tenner-Racz;Paul Racz

  • Simian Immunodeficiency Virus (SIV) gag DNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection

    Michael A. Egan;William A. Charini;Marcelo J. Kuroda;Jörn E. Schmitz

  • Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.

    Aruna Seth;Ilnour Ourmanov;Jorn E. Schmitz;Marcelo J. Kuroda

  • Replication-Defective Adenovirus Serotype 5 Vectors Elicit Durable Cellular and Humoral Immune Responses in Nonhuman Primates

    Sampa Santra;Michael S. Seaman;Ling Xu;Dan H. Barouch

  • Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity

    Angelique A. C. Lemckert;Shawn M. Sumida;Lennart Holterman;Ronald Vogels

Frequent Co-Authors

Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Jörn E. Schmitz
Jörn E. Schmitz Harvard Medical School
Dan H. Barouch
Dan H. Barouch Harvard Medical School
Sampa Santra
Sampa Santra Beth Israel Deaconess Medical Center
David C. Montefiori
David C. Montefiori Duke University
John W. Shiver
John W. Shiver United States Military Academy
Keith A. Reimann
Keith A. Reimann Harvard Medical School
Klara Tenner-Racz
Klara Tenner-Racz Bernhard Nocht Institute for Tropical Medicine
Paul Racz
Paul Racz Bernhard Nocht Institute for Tropical Medicine
Jaap Goudsmit
Jaap Goudsmit Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. One popular path is becoming a Nurse Practitioner, where understanding the immune system is essential. Many students seek the easiest online nurse practitioner programs to balance study with work and personal commitments.

Specializing further, a Psychiatric-Mental Health Nurse Practitioner (PMHNP) role is in high demand. Programs that offer robust clinical experience can make a big difference. Check out online pmhnp programs with clinical placement to ensure strong hands-on training.

Cost is a major consideration for students, so exploring the cheapest pmhnp programs can help you find budget-friendly options without sacrificing quality.

Advanced practice nurses often pursue a Doctor of Nursing Practice (DNP) degree. Understanding how much do dnps make is crucial for evaluating the return on investment and planning your career path effectively.

Best Scientists Citing Michelle A. Lifton

Trending Scientists

Recently Published Articles